Stock LMAT LEMAITRE VASCULAR, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
78.45 USD +0.99% Intraday chart for LeMaitre Vascular, Inc. +3.05% +38.21%
May. 08 Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing MT
May. 08 Lemaitre Vascular Insider Sold Shares Worth $379,991, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 718.7 823.9 1,097 1,012 1,264 1,744 - -
Enterprise Value (EV) 1 718.7 823.9 1,097 1,012 1,264 1,744 1,744 1,744
P/E ratio 40.9 x 38.9 x 40.2 x 49.5 x 42.4 x 44.3 x 40.4 x 36.7 x
Yield - - 0.88% 1.09% 0.99% 0.82% 0.87% -
Capitalization / Revenue 6.13 x 6.37 x 7.1 x 6.26 x 6.53 x 8.11 x 7.56 x 6.97 x
EV / Revenue 6.13 x 6.37 x 7.1 x 6.26 x 6.53 x 8.11 x 7.56 x 6.97 x
EV / EBITDA 27.2 x 22.5 x 24 x 25.9 x 27.5 x 28.8 x 26.1 x 23.5 x
EV / FCF 69 x 25.9 x 36.3 x 45.7 x 42.9 x 45.1 x 36.5 x 30.8 x
FCF Yield 1.45% 3.86% 2.75% 2.19% 2.33% 2.22% 2.74% 3.24%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 19,991 20,342 21,838 22,001 22,263 22,446 - -
Reference price 2 35.95 40.50 50.23 46.02 56.76 78.45 78.45 78.45
Announcement Date 2/6/20 2/25/21 2/24/22 2/23/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 117.2 129.4 154.4 161.7 193.5 215 230.8 250
EBITDA 1 26.4 36.68 45.78 39.04 45.91 60.46 66.74 74.05
EBIT 1 21.18 28.79 36.42 29.94 36.71 48.11 53.8 59.99
Operating Margin 18.07% 22.25% 23.59% 18.52% 18.97% 22.38% 23.31% 23.99%
Earnings before Tax (EBT) 1 21.68 27.36 34.29 27.49 39.48 52.15 57.94 65.74
Net income 1 17.93 21.22 26.91 20.64 30.1 40.04 44.28 49.38
Net margin 15.3% 16.4% 17.42% 12.77% 15.56% 18.62% 19.19% 19.75%
EPS 2 0.8800 1.040 1.250 0.9300 1.340 1.772 1.944 2.140
Free Cash Flow 1 10.42 31.82 30.22 22.15 29.49 38.64 47.8 56.54
FCF margin 8.89% 24.6% 19.57% 13.7% 15.24% 17.97% 20.71% 22.61%
FCF Conversion (EBITDA) 39.47% 86.74% 66.01% 56.73% 64.22% 63.91% 71.63% 76.35%
FCF Conversion (Net income) 58.09% 149.94% 112.31% 107.33% 97.94% 96.5% 107.95% 114.51%
Dividend per Share 2 - - 0.4400 0.5000 0.5600 0.6400 0.6800 -
Announcement Date 2/6/20 2/25/21 2/24/22 2/23/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 39.5 39.56 42.11 39.03 40.95 47.08 50.12 47.41 48.88 53.48 54.97 52.36 54.21 57.03 58.95
EBITDA 1 10.65 10.3 11.34 8.212 9.639 9.8 11.96 11.39 12.76 14.18 15.9 14.64 15.1 17.7 18.6
EBIT 1 8.301 7.928 8.891 6.15 6.967 7.874 9.632 9.18 10.21 11.87 12.87 11.4 12 12.98 14.17
Operating Margin 21.01% 20.04% 21.11% 15.76% 17.01% 16.73% 19.22% 19.36% 20.88% 22.2% 23.41% 21.77% 22.14% 22.76% 24.04%
Earnings before Tax (EBT) 1 7.905 7.996 5.548 6.148 7.798 8.017 10.32 9.826 11.31 12.8 13.88 12.44 13.06 14.44 15.73
Net income 1 6.175 6.038 3.515 5.456 5.627 6.04 8.098 7.502 8.465 9.887 10.62 9.548 10.01 10.73 11.64
Net margin 15.63% 15.26% 8.35% 13.98% 13.74% 12.83% 16.16% 15.82% 17.32% 18.49% 19.32% 18.23% 18.46% 18.82% 19.74%
EPS 2 0.2800 0.2700 0.1600 0.2500 0.2500 0.2700 0.3600 0.3300 0.3800 0.4400 0.4712 0.4212 0.4425 0.4760 0.5060
Dividend per Share 2 - 0.1250 0.1250 0.1250 0.1250 0.1400 0.1400 0.1400 0.1400 - 0.1600 0.1600 0.1600 - -
Announcement Date 2/24/22 4/28/22 7/28/22 10/27/22 2/23/23 5/2/23 8/1/23 11/1/23 2/27/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 10.4 31.8 30.2 22.1 29.5 38.6 47.8 56.5
ROE (net income / shareholders' equity) 12.9% 13.2% 12.6% 7.9% 10.6% 11.7% 12.5% -
ROA (Net income/ Total Assets) 10.5% 9.62% 9.86% 6.84% 9.16% 10.4% 11.1% -
Assets 1 170.7 220.6 272.8 301.6 328.6 386.9 400.7 -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 3.76 2.98 4.88 3.23 7.27 5.99 5.98 5
Capex / Sales 3.21% 2.31% 3.16% 2% 3.75% 2.79% 2.59% 2%
Announcement Date 2/6/20 2/25/21 2/24/22 2/23/23 2/27/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for LeMaitre Vascular, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
78.45 USD
Average target price
78.57 USD
Spread / Average Target
+0.15%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
LEMAITRE VASCULAR, INC. Stock LeMaitre Vascular, Inc.
+38.21% 1.74B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+12.15% 228B
DANAHER CORPORATION Stock Danaher Corporation
+14.90% 196B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+18.22% 141B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+29.15% 110B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.53% 65.88B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+16.92% 54.3B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+6.33% 52.39B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+10.93% 45.22B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+5.87% 37.12B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. LMAT Stock
  4. Financials LeMaitre Vascular, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW